Skip to main content

Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

All Products (364)

Clear all filters
Clear all filters

Umbralisib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

PI3K Inhibitor

Vismodegib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Solid Tumour / Hematologic (AML)

Drug Class / Mechanism

Hedgehog Pathway Inhibitor

Vistusertib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

mTOR Inhibitor

Zandelisib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

PI3K Inhibitor

Zimberelimab

Immunotherapy (Checkpoint Inhibitor)

Therapeutic Category

Immunotherapy (Checkpoint Inhibitor)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Anti-PD-1 mAb

Alisertib

Targeted Therapy (Investigational)

Therapeutic Category

Targeted Therapy (Investigational)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Polo-Like / Aurora Kinase Inhibitor

Barasertib

Targeted Therapy (Investigational)

Therapeutic Category

Targeted Therapy (Investigational)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Polo-Like / Aurora Kinase Inhibitor

Bavituximab

Immunotherapy (Investigational Checkpoint)

Therapeutic Category

Immunotherapy (Investigational Checkpoint)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

TIM-3 / LAG-3 / TIGIT Inhibitor

Belrestotug

Immunotherapy (Investigational Checkpoint)

Therapeutic Category

Immunotherapy (Investigational Checkpoint)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

TIM-3 / LAG-3 / TIGIT Inhibitor

Bezuclastinib

Targeted Therapy (Investigational)

Therapeutic Category

Targeted Therapy (Investigational)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Selective KIT D816V Inhibitor

BI-847325

Targeted Therapy (Investigational)

Therapeutic Category

Targeted Therapy (Investigational)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Polo-Like / Aurora Kinase Inhibitor

BMS-986258

Immunotherapy (Investigational Checkpoint)

Therapeutic Category

Immunotherapy (Investigational Checkpoint)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

TIM-3 / LAG-3 / TIGIT Inhibitor